TileBio
TileBio: Building foundation models that unlock the visual language of pathology to transform diagnostics and drug discovery.
$2.15M Seed ·
Source: startupintros.com
Funding history ↓Signals
Website registeredFeb 4, 2025 (21 months old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $2.15M | — | startupintros.com |
Timeline
- Website created
Founders and team
CW
Christopher Walsh Co-Founder / CEO & CTOsource: tilebio.comDC
David Chang Co-Founder / CMOsource: tilebio.comJQ
John Quesne FounderKY
Ke Yuan Co-Founder / CSOsource: tilebio.com
Investors
Companies like TileBio
AAignostics$34M Series B+ · Oct 2024
EExciting Instruments$5M Seed · Nov 2024
EElement Biosciences$175M Series B+ · Jun 2026
LLightcast$27M Series B+ · Apr 2026
SSingleCell BiotechnologyPre SeedEExo Therapeutics$78M Series B+ · Oct 2021
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/tilebio (get a free API key).